Duration of Targeted Therapy for Metastatic Renal Cell Carcinoma: A Review of Current Practices.
- Published in:
- Oncology, 2012, v. 82, n. 4, p. 189, doi. 10.1159/000336888
- By:
- Publication type:
- Article
Works matching IS 0030-2414 AND VI 82 AND IP 4 AND DT 2012
Results: 8
1
2
The Clinical Effect of the Inhibitor of Apopotosis Protein Livin in Melanoma.
- Published in:
- Oncology, 2012, v. 82, n. 4, p. 197, doi. 10.1159/000334234
- By:
- Publication type:
- Article
3
MicroRNA-372 Is Associated with Poor Prognosis in Colorectal Cancer.
- Published in:
- Oncology, 2012, v. 82, n. 4, p. 205, doi. 10.1159/000336809
- By:
- Publication type:
- Article
4
Development of Nanoaptamers Using a Mesoporous Silica Model Labeled with Tc for Cancer Targeting.
- Published in:
- Oncology, 2012, v. 82, n. 4, p. 213, doi. 10.1159/000337226
- By:
- Publication type:
- Article
5
First-Line Bevacizumab-Containing Therapy for Triple-Negative Breast Cancer: Analysis of 585 Patients Treated in the ATHENA Study.
- Published in:
- Oncology, 2012, v. 82, n. 4, p. 218, doi. 10.1159/000336892
- By:
- Publication type:
- Article
6
Hematologic Safety of Breast Cancer Chemotherapies in Patients with Hepatitis B or C Virus Infection.
- Published in:
- Oncology, 2012, v. 82, n. 4, p. 228, doi. 10.1159/000336904
- By:
- Publication type:
- Article
7
Tumour-Associated Trypsin Inhibitor TATI Is a Prognostic Marker in Colorectal Cancer.
- Published in:
- Oncology, 2012, v. 82, n. 4, p. 234, doi. 10.1159/000336080
- By:
- Publication type:
- Article
8
A Phase I Study of Infusional 5-Fluorouracil, Leucovorin, Oxaliplatin and Irinotecan in Japanese Patients with Advanced Colorectal Cancer Who Harbor UGT1A1*1/*1,*1/*6 or *1/*28.
- Published in:
- Oncology, 2012, v. 82, n. 4, p. 242, doi. 10.1159/000337225
- By:
- Publication type:
- Article